A new post-authorization safety analysis of Pfizer’s Abrysvo RSV vaccine
found that women who received the vaccine were 29% more likely to
experience hypertensive disorders, including preeclampsia. The
Pfizer-funded researchers cautioned that their findings are not
conclusive.Vaccinating against respiratory syncytial virus (RSV) during pregnancy
may increase the risk of pregnancy complications and lead to premature
birth and infection, according to a new study published in JAMA Network Open.
Source
No comments:
Post a Comment